Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Drug Alcohol Depend. 2021 May 21;225:108764. doi: 10.1016/j.drugalcdep.2021.108764

Figure 2: Histograms of medication uptake by month and medication type in a commercially insured cohort of individuals initiating medication for opioid use disorder in 2018.

Figure 2:

XR-BUP=Extended-release buprenorphine; XR-NTX=extended-release naltrexone; M-BUP=sublingual buprenorphine (mono- or co-formulated with naloxone). For each histogram, the vertical axis is the percent of total initiations of the given medication that occurred on a given month. For example, of all M-BUP initiations, just under 10% occurred in January.